Horizon Therapeutics Public Ltd Co

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/8/2023

Shares

935,067

Value ($000)

108,178

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/8/2023	108,178	0.0%	935,067	9/30/2023
2023 Q2	8/10/2023	97,142	0.0%	944,504	6/30/2023
2023 Q1	5/12/2023	101,558	0.0%	930,527	3/31/2023
2022 Q4	2/13/2023	103,512	0.0%	909,597	12/31/2022
2022 Q3	11/14/2022	58,090	0.0%	938,599	9/30/2022
2022 Q2	8/15/2022	71,715	0.0%	899,128	6/30/2022
2022 Q1	5/13/2022	82,737	0.0%	786,397	3/31/2022
2021 Q4	2/11/2022	83,748	0.0%	777,169	12/31/2021
2021 Q3	11/16/2021	84,291	0.0%	769,497	9/30/2021
2021 Q2	8/16/2021	74,101	0.0%	791,331	6/30/2021
2021 Q1	5/17/2021	71,815	0.0%	780,255	3/31/2021
2020 Q4	2/16/2021	56,685	0.0%	774,913	12/31/2020
2020 Q3	11/13/2020	61,025	0.0%	785,587	9/30/2020
2020 Q2	8/20/2020	87,877	0.0%	1,581,073	6/30/2020
2020 Q1	5/15/2020	47,366	0.0%	1,599,106	3/31/2020
2019 Q4	2/7/2020	59,553	0.0%	1,645,088	12/31/2019